Abstract:Objective: Tumor metastasis is a complex, multistep process that depends on tumor cells and their communication with the tumor microenvironment. A p53 gain-of-function mutant has been shown to enhance the tumorigenesis, invasion, and metastasis abilities of tumor cells. This study aimed to investigate the roles of p53 R273H mutation in the tumor microenvironment. Methods: The in vitro and in vivo effects of the p53 R273H mutant on the invasion and metastasis of HCT116 cells were investigated. Exosomes from wild-type and HCT116-TP53(R273H) cells were cocultured with mouse embryonic fibroblasts (MEFs). The roles of differentially expressed exosomal microRNAs identified by microarray analysis were investigated. The functions of the p53 R273H mutant in tumor cells were also investigated via gene expression microarray and quantitative polymerase chain reaction (qPCR) analyses. Results: Introducing p53 R273H mutant into HCT116 cells significantly potentiated pulmonary metastasis in vivo. In the presence of exosomes derived from HCT116-TP53(R273H) cells, the exosomes were taken up by MEFs and became activated. Microarray analysis showed that the p53 R273H mutation increased the exosomal levels of miR-21-3p and miR-769-3p. Intriguingly, in clinical samples, miR-21-3p and miR-769-3p levels were significantly higher in patients with a p53 mutation than in those without this mutation. Furthermore, both miR-21-3p and miR-769-3p activated fibroblasts and exerted a synergistic effect via their target genes on the transforming growth factor-beta (TGF-beta)/Smad signaling pathway. The activated fibroblasts excreted cytokine TGF-beta and may have reciprocally induced cancer cells to undergo epithelial-mesenchymal transition (EMT). Indeed, HCT116-TP53(R273H) cells showed increased expression of ZEB1 and SNAI2 and decreased transcription of several cell adhesion molecules. Conclusions: The mutant p53-exosomal miR-21-3p/miR-769-3p-fibroblast-cytokine circuit appears to be responsible for communication between tumor and stromal cells, with exosomal miRNAs acting as a bridge. miR-21-3p and miR-769-3p are potential predictive markers of pulmonary metastasis and candidate targets for therapeutic interventions.

Mutant P53 Induces EZH2 Expression and Promotes Epithelial-Mesenchymal Transition by Disrupting P68-Drosha Complex Assembly and Attenuating Mir-26A Processing

Mutant p53 increases exosome-mediated transfer of miR-21-3p and miR-769-3p to promote pulmonary metastasis.

Mutant p53 achieves function by regulating EGR1 to induce epithelial mesenchymal transition

Mutant P53-R273h Gains New Function in Sustained Activation of EGFR Signaling Via Suppressing Mir-27A Expression

Mutant p53 (p53-R248Q) functions as an oncogene in promoting endometrial cancer by up-regulating REGγ.

miR-615-3p promotes the epithelial-mesenchymal transition and metastasis of breast cancer by targeting PICK1/TGFBRI axis

Mir-106B Promotes Cell Invasion and Metastasis Via PTEN Mediated EMT in ESCC.

EZH2-Mediated Microrna-139-5p Regulates Epithelial-Mesenchymal Transition and Lymph Node Metastasis of Pancreatic Cancer.

Elevated Expression of P53 Gain-of-function Mutation R175H in Endometrial Cancer Cells Can Increase the Invasive Phenotypes by Activation of the EGFR/PI3K/AKT Pathway

A role for p53 in the regulation of extracellular matrix metalloproteinase inducer in human cancer cells.

Transcription factor p53-mediated activation of miR-519d-3p and downregulation of E2F1 attenuates prostate cancer growth and metastasis

53BP1 suppresses epithelial–mesenchymal transition by downregulating ZEB1 through microRNA‐200b/429 in breast cancer

SMYD3 Promotes Epithelial Ovarian Cancer Metastasis by Down-Regulating P53 Protein Stability and Promoting P53 Ubiquitination.

Mutant P53 Drives Cancer Metastasis Via RCP-Mediated Hsp90α Secretion.

Methylation of EZH2 by PRMT1 regulates its stability and promotes breast cancer metastasis

EZH2-Mediated Microrna-375 Upregulation Promotes Progression of Breast Cancer Via the Inhibition of FOXO1 and the P53 Signaling Pathway.

MiR-146b-5p Promotes Metastasis and Induces Epithelial-Mesenchymal Transition in Thyroid Cancer by Targeting ZNRF3.

Enhancer of zeste homolog 2 blockade by RNA interference is implicated with inhibited proliferation, invasion and promoted apoptosis in endometrial carcinoma.

MiR-361-3p Regulates ERK1/2-induced EMT Via DUSP2 Mrna Degradation in Pancreatic Ductal Adenocarcinoma.

Abstract 1643: p53 family and oncogenic signaling in cancer metastasis

Mir-300 Promotes Proliferation and Emt-Mediated Colorectal Cancer Migration and Invasion by Targeting P53